dacarbazine has been researched along with Anemia, Hemolytic, Acquired in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bardier, A; Blot, E; Decaudin, D; Pouillart, P; Veyradier, A; Zagame, OL | 1 |
1 other study(ies) available for dacarbazine and Anemia, Hemolytic, Acquired
Article | Year |
---|---|
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
Topics: ADAM Proteins; ADAMTS13 Protein; Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; CA-19-9 Antigen; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Fatal Outcome; Female; Humans; Ifosfamide; Jaundice; Metalloendopeptidases; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paraneoplastic Syndromes; Sarcoma; Thrombocytopenia; von Willebrand Factor | 2002 |